Literature DB >> 11469791

Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction.

M F Sisemore1, J Zheng, J C Yang, D A Thompson, C G Plopper, G A Cortopassi, B D Hammock.   

Abstract

Leukotoxin, a cytochrome P450-derived epoxide of linoleic acid, has been implicated as a causative factor in acute respiratory distress syndrome. Conversion of this fatty acid epoxide to leukotoxin diol by epoxide hydrolase has been hypothesized as the critical activation step in leukotoxin-induced cellular toxicity. In both human and insect cells, we observed that leukotoxin diol causes acute cellular toxicity and that cyclosporin A, an inhibitor of the mitochondrial permeability transition, ameliorates leukotoxin diol-associated toxicity. To evaluate mitochondria as a target of leukotoxin diol, multiple aspects of mitochondrial integrity were evaluated in both cell- and organelle-based assays. Leukotoxin diol specifically activated the mitochondrial permeability transition, resulting in release of cytochrome c and subsequent cell death. Pretreatment with cyclosporin A inhibited these effects and, furthermore, limited in vivo toxicity. While the mechanisms underlying leukotoxin-mediated toxicity remain to be fully elucidated, the observation that leukotoxin diol disrupts mitochondrial function specifically through activation of the mitochondrial permeability transition suggests at least one mechanism through which leukotoxin diol may exert its activity in physiological contexts. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469791     DOI: 10.1006/abbi.2001.2434

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  25 in total

1.  The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue.

Authors:  Matthew D Lynes; Luiz O Leiria; Morten Lundh; Alexander Bartelt; Farnaz Shamsi; Tian Lian Huang; Hirokazu Takahashi; Michael F Hirshman; Christian Schlein; Alexandra Lee; Lisa A Baer; Francis J May; Fei Gao; Niven R Narain; Emily Y Chen; Michael A Kiebish; Aaron M Cypess; Matthias Blüher; Laurie J Goodyear; Gökhan S Hotamisligil; Kristin I Stanford; Yu-Hua Tseng
Journal:  Nat Med       Date:  2017-03-27       Impact factor: 53.440

Review 2.  Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

Authors:  Jogen Atone; Karen Wagner; Kenji Hashimoto; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-05       Impact factor: 3.072

Review 3.  Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium.

Authors:  Irina A Kirpich; Dennis R Warner; Wenke Feng; Swati Joshi-Barve; Craig J McClain; Devanshi Seth; Wei Zhong; Zhanxiang Zhou; Natalia A Osna; Kusum K Kharbanda
Journal:  Alcohol       Date:  2019-05-23       Impact factor: 2.405

Review 4.  Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies.

Authors:  Kelsey Hildreth; Sean D Kodani; Bruce D Hammock; Ling Zhao
Journal:  J Nutr Biochem       Date:  2020-08-20       Impact factor: 6.048

5.  Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment.

Authors:  Di Yu; Marie Hennebelle; Demetrios J Sahlas; Joel Ramirez; Fuqiang Gao; Mario Masellis; Hugo Cogo-Moreira; Richard H Swartz; Nathan Herrmann; Pak Cheung Chan; Jacqueline A Pettersen; Donald T Stuss; Sandra E Black; Ameer Y Taha; Walter Swardfager
Journal:  Transl Stroke Res       Date:  2018-11-15       Impact factor: 6.829

6.  Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation.

Authors:  Vincent C Tam; Oswald Quehenberger; Christine M Oshansky; Rosa Suen; Aaron M Armando; Piper M Treuting; Paul G Thomas; Edward A Dennis; Alan Aderem
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

7.  Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.

Authors:  John M Seubert; Christopher J Sinal; Joan Graves; Laura M DeGraff; J Alyce Bradbury; Craig R Lee; Kerry Goralski; Michelle A Carey; Ayala Luria; John W Newman; Bruce D Hammock; John R Falck; Holly Roberts; Howard A Rockman; Elizabeth Murphy; Darryl C Zeldin
Journal:  Circ Res       Date:  2006-07-20       Impact factor: 17.367

8.  Metabolomics reveals increased isoleukotoxin diol (12,13-DHOME) in human plasma after acute Intralipid infusion.

Authors:  Lindsay M Edwards; Nathan G Lawler; Sonja B Nikolic; James M Peters; James Horne; Richard Wilson; Noel W Davies; James E Sharman
Journal:  J Lipid Res       Date:  2012-06-19       Impact factor: 5.922

9.  The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity.

Authors:  John W Newman; Christophe Morisseau; Todd R Harris; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

10.  Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.

Authors:  Ketul R Chaudhary; Beshay N M Zordoky; Matthew L Edin; Nasser Alsaleh; Ayman O S El-Kadi; Darryl C Zeldin; John M Seubert
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-16       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.